Skip to main content
OpenTrials
Completed

NCT Number: NCT04337047

Distress in Crisis Situations During COVID-19

There are many scales for screening or assessing the impact of a disease. These scales are generally used to diagnose or assess the severity of a disease and are carried out at the request of a physician by the patient. Conversational agents could make it possible to administer these questionnaires remotely, analyse them and use the results on a large scale, without prior medical intervention.

The main objective of this study is to quantify and qualify the distress of a large population in times of pandemic crisis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Wefight

Montpellier, 34000, France

About this study

The Peritraumatic Distress Inventory is the standard tool designed to assess distress in times of crisis. It consists of 13 questions.

Questions will be submitted to the participants from the Vik chatbot. Responses will be analysed and compared according to the demographics and pathologies encountered.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years old
  • Collection of the subject's non-opposition
  • Patient registration on Vik breast, Vik asthma, Vik migraine, Vik depression

Exclusion criteria

  • Patient unable to formulate non-opposition

Treatment and study plan

questionnaire assesment

Other

questionnaire assesment

Primary outcomes

  1. quantify and qualify distress over a large population in times of pandemic crisis.

    Time frame: 1 month

Secondary outcomes

  1. qualify demographic data vs distress over a large population in times of pandemic crisis.

    Time frame: 1 month

Sponsors and collaborators

Lead sponsor

Wefight

Industry

Registry information

Official study title

Distress During the COVID-19 Pandemic in France: a National Assessment of At-risk Populations

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Apr 7, 2020
Registry last updated
May 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.